title: Case of erlotinib-induced photosensitivity.
authors.affiliation: Department of Dermatology and Allergology, Juntendo University Graduate School of Medicine, Bunkyo-ku, Tokyo, Japan.
authors.forename: Tatsuo
authors.initials: T
authors.lastname: Fukai
authors.forename: Toshio
authors.initials: T
authors.lastname: Hasegawa
authors.forename: Ayako
authors.initials: A
authors.lastname: Nagata
authors.forename: Maiko
authors.initials: M
authors.lastname: Matsumura
authors.forename: Yukako
authors.initials: Y
authors.lastname: Kudo
authors.forename: Eriko
authors.initials: E
authors.lastname: Shiraishi
authors.forename: Yuki
authors.initials: Y
authors.lastname: Kamiya
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Hirasawa
authors.forename: Shigaku
authors.initials: S
authors.lastname: Ikeda
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy; D000077192:Adenocarcinoma of Lung; D000368:Aged; D017454:Dermatitis, Photoallergic / Q000175:diagnosis / Q000209:etiology*; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D000069347:Erlotinib Hydrochloride; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy; D008297:Male; D010328:Patch Tests; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride; C512478:EGFR protein, human; D066246:ErbB Receptors